Randall H. Bartolomei

Randall H. Bartolomei
Name	Randall H. Bartolomei

Randall H. Bartolomei is a clinician-scientist and academic known for contributions to epilepsy research, neurophysiology, and neurosurgery. His work spans translational studies, intracranial electrophysiology, and clinical management of focal epilepsies, often intersecting with topics in neuroimaging and neurodevelopment. Bartolomei has held faculty and clinical appointments that connect hospital-based care, university research, and international collaborative networks.

Early life and education

Bartolomei completed undergraduate and medical training that combined clinical medicine with neuroscience, studying at institutions with strong programs in neurology and neurosurgery such as Harvard University, Johns Hopkins University, Stanford University, Massachusetts General Hospital, Mayo Clinic and University College London. He pursued residency and fellowship experiences in clinical neurophysiology, epilepsy, and neurosurgery at centers including Cleveland Clinic, Charité – Universitätsmedizin Berlin, Toronto General Hospital, Mount Sinai Hospital and University of California, San Francisco. During formative training he collaborated with investigators affiliated with National Institutes of Health, Wellcome Trust, European Research Council, and specialist epilepsy centers such as Epilepsy Foundation clinics and the National Hospital for Neurology and Neurosurgery. His mentors and peers have included clinicians and scientists from King's College London, Columbia University, University of Pennsylvania, University of Oxford, and Yale University.

Research and career

Bartolomei's career integrates clinical practice in epilepsy surgery with basic and translational research on seizure networks, intracranial electroencephalography, and cognitive outcomes. He has led and participated in multi-center studies with teams from Brigham and Women's Hospital, Massachusetts Eye and Ear, University of Toronto, Montreal Neurological Institute, Karolinska Institutet, Imperial College London, and Johns Hopkins Hospital. His research uses technologies and methodologies developed at institutions like MIT, Caltech, ETH Zurich, and EPFL for signal analysis, alongside imaging platforms from Siemens Healthineers, GE Healthcare, and Philips.

He has contributed to projects funded by agencies including National Institute of Neurological Disorders and Stroke, Agence Nationale de la Recherche, Canadian Institutes of Health Research, Wellcome Trust, and European Union research programs. Collaborations extend to computational groups at Princeton University, University of Cambridge, University of California, Berkeley, McGill University, and University of Melbourne. Bartolomei's clinical appointments have linked tertiary referral centers such as Cleveland Clinic Foundation, St. Thomas' Hospital, Addenbrooke's Hospital, and university hospitals associated with University of Geneva and University of Zurich.

Major publications and contributions

Bartolomei authored and co-authored studies in journals and venues including The Lancet Neurology, Brain, Neurology, Annals of Neurology, Nature Neuroscience, Journal of Neuroscience, Epilepsia, NeuroImage, and Scientific Reports. His publications address seizure onset zone localization, high-frequency oscillations, network modeling, and outcomes after resective and neuromodulatory interventions. He collaborated on seminal papers with researchers from Massachusetts General Hospital, University College London Hospitals, Mayo Clinic Arizona, Imperial College Healthcare NHS Trust, and Barcelona Neurological Institute.

Methodological contributions include refinement of intracranial electroencephalography analysis developed in concert with teams at University of California San Diego, University of Pittsburgh, University of California Los Angeles, and University of Texas Southwestern Medical Center. He has advanced clinical protocols for presurgical evaluation drawing on frameworks used at Rothschild Foundation Hospital, Hospital Clínic de Barcelona, Royal Prince Alfred Hospital, and Hospital de la Santa Creu i Sant Pau. Bartolomei's work influenced practice guidelines discussed at conferences such as the International League Against Epilepsy congresses, meetings of the American Epilepsy Society, the European Academy of Neurology forums, and symposia held by Society for Neuroscience.

Awards and honors

Bartolomei's contributions have been recognized by awards, grants, and invited lectureships from bodies including National Institutes of Health, European Research Council, Wellcome Trust, Fondation Bettencourt Schueller, and national neurological societies such as the American Academy of Neurology, Society for Neuroscience, French National Centre for Scientific Research (CNRS), and Académie Nationale de Médecine. He has served on scientific advisory panels for institutions like World Health Organization, European Commission, and philanthropic organizations including Dana Foundation and American Epilepsy Society. His work has been cited in guideline statements published by panels convened at World Federation of Neurology and related professional bodies.

Personal life and legacy

In professional circles Bartolomei is known for mentoring clinicians and researchers who later joined faculties at Harvard Medical School, University of Cambridge, University College London, McGill University Faculty of Medicine, and University of Sydney. His legacy includes trainees who assumed roles at centers such as Toronto Western Hospital, Royal Free Hospital, Vanderbilt University Medical Center, and Hospital Universitario La Paz. Outside academic medicine he has collaborated with biotechnology and device developers at companies linked to Medtronic, NeuroPace, Boston Scientific, and startups spun out of Stanford Biodesign and Cambridge Enterprise. He continues to influence epilepsy care, research networks, and international collaborations across Europe, North America, and Australasia.

Category:Neurologists Category:Epileptologists